ANCHOR LEAD: ANOTHER CHOICE NOW EXISTS FOR PEOPLE WITH SEVERE ALZHEIMER’S DISEASE, ELIZABETH TRACEY REPORTS
Managing the symptoms of severe Alzheimer’s disease may now get a bit easier with a study proving the utility of galantamine published recently in the Lancet. Constantine Lyketsos, an Alzheimer’s disease expert at Johns Hopkins, says this is good news.
LYKETSOS: Bottom line impact for patients is they have another choice. If they are in severe disease they have the choice of using donepezil, Aricept, or galantamine, for some of the cognitive symptoms that Alzheimer’s patients develop and there are modest functional benefits. The study does not address whether someone who’s been on razadine through moderate disease should continue on it in severe disease, but it stands to reason to think that they probably should continue on it in light of this evidence. :30
Lyketsos says studies such as this one may help improve insurance company and Medicare coverage of the drug. I’m Elizabeth Tracey reporting.